نتایج جستجو برای: rotavirus vaccine

تعداد نتایج: 115323  

Journal: :World journal of pediatrics : WJP 2015
Ching-Min Wang Shou-Chien Chen Kow-Tong Chen

BACKGROUND Rotaviruses remain the major cause of childhood diarrheal disease worldwide and of diarrheal deaths of infants and children in developing countries. The huge burden of childhood rotavirus-related diarrhea in the world continues to drive the remarkable pace of vaccine development. DATA SOURCES Research articles were searched using terms "rotavirus" and "rotavirus vaccine" in MEDLINE...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016
Jacqueline E Tate Anthony H Burton Cynthia Boschi-Pinto Umesh D Parashar

BACKGROUND Rotavirus vaccine is recommended for routine use in all countries globally. To facilitate decision making on rotavirus vaccine adoption by countries, help donors prioritize investments in health interventions, and monitor vaccine impact, we estimated rotavirus mortality for children <5 years of age from 2000 to 2013. METHODS We searched PubMed using the keyword "rotavirus" to ident...

Journal: :Pediatrics 1998

On February 3, 2006, a bovine-based pentavalent rotavirus vaccine (RotaTeq, Merck & Co Inc, Whitehouse Station, NJ) was licensed by the US Food and Drug Administration for use in infants in the United States. The American Academy of Pediatrics recommends routine immunization of infants with 3 doses of pentavalent rotavirus vaccine administered orally at 2, 4, and 6 months of age. The first dose...

Journal: :Journal of the Pediatric Infectious Diseases Society 2015
Kristine M Wylie George M Weinstock Gregory A Storch

BACKGROUND We observed an increase in the number of rotavirus cases in the St. Louis area during the 2012-2013 rotavirus season compared with recent seasons. We aimed to determine whether the rotavirus cases during the 2012-2013 rotavirus season were of types not included in licensed vaccines. METHODS Microbiology laboratories of 3 children's hospitals in St. Louis provided samples that were ...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2014
Jacqueline E Tate Umesh D Parashar

Vaccines are now available to combat rotavirus, the most common cause of severe diarrhea among children worldwide. We review clinical trial data for available rotavirus vaccines and summarize postlicensure data on effectiveness, impact, and safety from countries routinely using these vaccines in national programs. In these countries, rotavirus vaccines have reduced all-cause diarrhea and rotavi...

2014
Daniel Hungerford Roberto Vivancos Neil French Miren Iturriza-Gomara Nigel Cunliffe

INTRODUCTION Rotavirus is the most common cause of severe gastroenteritis in infants and young children worldwide. Currently 67 countries include rotavirus vaccine in childhood immunisation programmes, but uptake in Western Europe has been slow. In July 2013, rotavirus vaccine was introduced into the UK's routine childhood immunisation programme. Prior to vaccine introduction in the UK, rotavir...

2016
Naor Bar-Zeev Khuzwayo C. Jere Aisleen Bennett Louisa Pollock Jacqueline E. Tate Osamu Nakagomi Miren Iturriza-Gomara Anthony Costello Charles Mwansambo Umesh D. Parashar Robert S. Heyderman Neil French Nigel A. Cunliffe James Beard Amelia C. Crampin Carina King Sonia Lewycka Hazzie Mvula Tambosi Phiri Jennifer R. Verani Cynthia G. Whitney

BACKGROUND Rotavirus vaccines have been introduced in many low-income African countries including Malawi in 2012. Despite early evidence of vaccine impact, determining persistence of protection beyond infancy, the utility of the vaccine against specific rotavirus genotypes, and effectiveness in vulnerable subgroups is important. METHODS We compared rotavirus prevalence in diarrheal stool and ...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016
Naor Bar-Zeev Jacqueline E Tate Clint Pecenka Jean Chikafa Hazzie Mvula Richard Wachepa Charles Mwansambo Themba Mhango Geoffrey Chirwa Amelia C Crampin Umesh D Parashar Anthony Costello Robert S Heyderman Neil French Deborah Atherly Nigel A Cunliffe

BACKGROUND Rotavirus vaccination reduces childhood hospitalization in Africa, but cost-effectiveness has not been determined using real-world effectiveness and costing data. We sought to determine monovalent rotavirus vaccine cost-effectiveness in Malawi, one of Africa's poorest countries and the first Gavi-eligible country to report disease reduction following introduction in 2012. METHODS T...

Journal: :The Journal of infectious diseases 2005
Laura Jean Podewils Lynn Antil Erik Hummelman Joseph Bresee Umesh D Parashar Richard Rheingans

BACKGROUND New rotavirus vaccines may soon be licensed, and decisions regarding implementation of their use will likely be based on the health and economic benefits of vaccination. METHODS We estimated the benefits and cost-effectiveness of rotavirus vaccination in Asia by using published estimates of rotavirus disease incidence, health care expenditures, vaccine coverage rates, and vaccine e...

Journal: :Jornal de pediatria 2006
Alexandre C Linhares Luisa Lina Villa

OBJECTIVE To briefly review strategies aimed at the development of rotavirus and HPV vaccines, with emphasis on the current status of studies assessing the safety, reactogenicity, immunogenicity and efficacy of recently developed vaccines. SOURCES OF DATA This review focuses on articles published from 1996 to 2006, mainly those from the last five years, with special emphasis on data obtained ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید